These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 18929814

  • 1. Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus.
    Wang SS, Chou NK, Chi NH, Wu IH, Chen YS, Yu HY, Huang SC, Wang CH, Ko WJ, Tsao CI, Sun CD.
    Transplant Proc; 2008 Oct; 40(8):2607-8. PubMed ID: 18929814
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E, Spagnoletti G, Salerno MP, Pedroso JA, Romagnoli J, Citterio F.
    Clin Transplant; 2013 Oct; 27(4):E359-67. PubMed ID: 23710603
    [Abstract] [Full Text] [Related]

  • 3. The survival of heart transplant recipients using cyclosporine and everolimus is not inferior to that using cyclosporine and mycophenolate.
    Wang SS, Chou NK, Chi NH, Huang SC, Wu IH, Wang CH, Yu HY, Chen YS, Tsao CI, Ko WJ, Shun CT.
    Transplant Proc; 2010 Apr; 42(3):938-9. PubMed ID: 20430209
    [Abstract] [Full Text] [Related]

  • 4. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roth D, Kupin W, Nicolas M, Ruiz P, Rosen A, Miller J.
    Transplantation; 2004 Jan 27; 77(2):244-51. PubMed ID: 14742989
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study.
    Potena L, Prestinenzi P, Bianchi IG, Masetti M, Romani P, Magnani G, Fallani F, Coccolo F, Russo A, Ponticelli C, Rapezzi C, Grigioni F, Branzi A.
    J Heart Lung Transplant; 2012 Jun 27; 31(6):565-70. PubMed ID: 22341702
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular risk profile in kidney transplant recipients treated with two immunosuppressive regimens: tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine.
    Spagnoletti G, Citterio F, Favi E, Rossi E, Delreno F, De Santis I, Salerno MP, Gargiulo A, Castagneto M.
    Transplant Proc; 2009 May 27; 41(4):1175-7. PubMed ID: 19460509
    [Abstract] [Full Text] [Related]

  • 7. Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study.
    Viganò M, Dengler T, Mattei MF, Poncelet A, Vanhaecke J, Vermes E, Kleinloog R, Li Y, Gezahegen Y, Delgado JF, RAD A2411 Study Investigators.
    Transpl Infect Dis; 2010 Feb 27; 12(1):23-30. PubMed ID: 19744284
    [Abstract] [Full Text] [Related]

  • 8. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E, Citterio F, Spagnoletti G, Gargiulo A, Delreno F, Romagnoli J, Castagneto M.
    Transplant Proc; 2009 May 27; 41(4):1152-5. PubMed ID: 19460503
    [Abstract] [Full Text] [Related]

  • 9. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Zucker MJ, Baran DA, Arroyo LH, Goldstein DJ, Neacy C, Mele L, Weinberg AD, Prendergast TW, Ribner HS.
    Transplant Proc; 2005 Jun 27; 37(5):2231-9. PubMed ID: 15964386
    [Abstract] [Full Text] [Related]

  • 10. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, Reichart B, Hagl C, Kaczmarek I.
    Transplantation; 2013 Feb 27; 95(4):629-34. PubMed ID: 23423270
    [Abstract] [Full Text] [Related]

  • 11. Cardiac allograft vasculopathy compared by intravascular ultrasound sonography: everolimus to mycophenolate mofetil--one single-center experience.
    Chou NK, Jan CF, Chi NH, Lee CM, Wu IH, Huang SC, Chen YS, Yu HY, Tsao CI, Ko WJ, Chu SH, Wang SS.
    Transplant Proc; 2012 May 27; 44(4):897-9. PubMed ID: 22564578
    [Abstract] [Full Text] [Related]

  • 12. Clinical experience of tacrolimus with everolimus in heart transplantation.
    Wang SS, Chou NK, Chi NH, Huang SC, Wu IH, Wang CH, Yu HY, Chen YS, Tsao CI, Ko WJ, Shun CT.
    Transplant Proc; 2012 May 27; 44(4):907-9. PubMed ID: 22564581
    [Abstract] [Full Text] [Related]

  • 13. Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation.
    Annemans L, Lemkuhl H, Tenderich G, Schulz U, Yang XL, Ricci JF, Hetzer R.
    Transplant Proc; 2007 Dec 27; 39(10):3306-12. PubMed ID: 18089377
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM, Klupp J, Glanemann M, Junge G, Pfitzmann R, Bahra M, Radtke C, Neumann U, Neuhaus R, Neuhaus P.
    Clin Transplant; 2006 Dec 27; 20(3):272-83. PubMed ID: 16824141
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S, Prograf Study Group.
    Transplantation; 2003 Apr 27; 75(8):1213-20. PubMed ID: 12717205
    [Abstract] [Full Text] [Related]

  • 16. Differential pharmacokinetic interaction of tacrolimus and cyclosporine on everolimus.
    Kovarik JM, Curtis JJ, Hricik DE, Pescovitz MD, Scantlebury V, Vasquez A.
    Transplant Proc; 2006 Dec 27; 38(10):3456-8. PubMed ID: 17175302
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
    Fuchs U, Zittermann A, Ensminger SM, Schulz U, Gummert JF.
    Transpl Immunol; 2014 Aug 27; 31(2):87-91. PubMed ID: 24932812
    [Abstract] [Full Text] [Related]

  • 18. Combination of everolimus and tacrolimus in kidney transplant patients with intolerance to mycophenolate mofetil/mycophenolic acid.
    Balda S, Inza A, Odriozola N, Zárraga S, García-Erauskin G, Lampreabe I.
    Transplant Proc; 2009 Aug 27; 41(6):2095-8. PubMed ID: 19715841
    [Abstract] [Full Text] [Related]

  • 19. A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients.
    Bara C, Dengler T, Hack MA, Ladenburger S, Lehmkuhl HB.
    Transplant Proc; 2013 Aug 27; 45(6):2387-92. PubMed ID: 23953553
    [Abstract] [Full Text] [Related]

  • 20. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE.
    Transplantation; 2003 Jun 27; 75(12):2048-53. PubMed ID: 12829910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.